You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Suppliers and packagers for PEDIATRIC ADVIL


✉ Email this page to a colleague

« Back to Dashboard


PEDIATRIC ADVIL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings PEDIATRIC ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA Haleon US Holdings LLC 0573-0191-20 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-20) / 15 mL in 1 BOTTLE, DROPPER 1998-01-30
Haleon Us Holdings PEDIATRIC ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA Haleon US Holdings LLC 0573-0191-22 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-22) / 15 mL in 1 BOTTLE, DROPPER 1998-01-30
Haleon Us Holdings PEDIATRIC ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA Haleon US Holdings LLC 0573-0191-50 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-50) / 30 mL in 1 BOTTLE, DROPPER 1998-01-30
Haleon Us Holdings PEDIATRIC ADVIL ibuprofen SUSPENSION/DROPS;ORAL 020812 NDA Haleon US Holdings LLC 0573-0191-75 1 BOTTLE, DROPPER in 1 CARTON (0573-0191-75) / 22.5 mL in 1 BOTTLE, DROPPER 1998-01-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: PEDIATRIC ADVIL

Last updated: July 29, 2025

Introduction
Pediatric Advil, a widely used over-the-counter (OTC) medication for children, primarily comprises ibuprofen—an NSAID (non-steroidal anti-inflammatory drug). As a trusted brand, its supply chain dynamics are critical for pharmaceutical manufacturers, distributors, and healthcare providers. Understanding the key suppliers involved in the production of Pediatric Advil offers insights into market security, regulatory compliance, and potential vulnerabilities within the supply chain.

Active Pharmaceutical Ingredient (API) Suppliers
The core component of Pediatric Advil is ibuprofen, whose quality and supply are essential to product integrity. Major API producers for ibuprofen include:

  • Novartis (Switzerland): Historically one of the leading suppliers of ibuprofen APIs, Novartis’s manufacturing facilities in Europe have supplied APIs globally, adhering to stringent GMP standards.

  • Mitsutomo (Japan): A key supplier for high-purity ibuprofen APIs, Mitsutomo emphasizes quality control, which is critical for pediatric formulations.

  • Ajanta Pharma (India): An emerging API producer that supplies ibuprofen to various pharmaceutical firms, including those producing OTC pediatric medications.

  • Daiichi Sankyo (Japan): Supplies high-quality API used in various OTC and prescription medications.

These companies are subject to global regulatory audits, including the U.S. FDA and EMA inspections, ensuring compliance with Good Manufacturing Practices (GMP). The sourcing of ibuprofen APIs often involves complex supply chains with multiple tiers, which can influence the pricing and availability of Pediatric Advil.

Excipients and Formulation Components
Apart from the API, Pediatric Advil formulations require excipients such as flavoring agents, sweeteners, stabilizers, and coloring agents. Suppliers for these components include:

  • Ingredion Incorporated (USA): Supplies sucrose, sorbitol, and other sweeteners used in pediatric formulations.

  • Givaudan (Switzerland): Provides flavoring agents specifically designed for pediatric medications, ensuring palatability.

  • BASF (Germany): Supplies coloring agents and stabilizers compatible with oral liquid formulations.

The quality and sourcing of excipients are regulated by pharmacopeias, with suppliers needing to comply with strict standards to avoid contamination or adverse pediatric reactions.

Packaging Material Suppliers
Child-safe packaging is essential for OTC pediatric medicines. Leading suppliers include:

  • Gerresheimer (Germany): Manufactures glass and plastic bottles designed for pediatric liquid medications, emphasizing child-resistant features.

  • Berry Global (USA): Supplies child-resistant caps, closures, and secondary packaging.

  • Tetra Pak (Sweden): Provides laminated packaging solutions that protect the medication from moisture and contamination.

These materials are subject to safety standards and regulatory approvals to prevent accidental ingestion or tampering.

Manufacturing and Contract Manufacturing Organizations (CMOs)
Some pharmaceutical companies outsource production to specialized CMOs to meet demand or leverage technical expertise:

  • Catalent (USA): Provides formulation development and manufacturing services for pediatric OTC drugs, including liquid and chewable forms.

  • Recipharm (Sweden): Manufactures liquid formulations and serialized packaging for pediatric medicines.

  • Famar (Greece): Offers end-to-end manufacturing solutions aligned with regulatory standards.

Engaging reputable CMOs ensures consistent quality and compliance with evolving regulatory requirements.

Distribution and Logistics Suppliers
Efficient logistics are vital for maintaining the integrity of Pediatric Advil:

  • DHL Supply Chain: Provides temperature-controlled transport services for sensitive pharmaceutical products.

  • FedEx Pharma Solutions: Offers specialized handling for OTC and pediatric medicines, ensuring compliance with safety regulations.

  • UPS Healthcare: Delivers nationwide and global distribution, including cold-chain logistics where necessary.

Regulatory and Quality Assurance
Suppliers must comply with stringent regulatory standards, such as:

  • U.S. Food and Drug Administration (FDA): Ensures API and excipient suppliers meet GMP requirements.

  • European Medicines Agency (EMA): Sets guidelines applicable to suppliers serving European markets.

  • World Health Organization (WHO): Provides normative guidance on quality standards for pharmaceutical ingredients and excipients.

Maintaining high-quality supplier relationships mitigates risks of contamination, counterfeiting, and supply disruptions.

Supply Chain Challenges & Risks
The global supply chain faces challenges including:

  • Raw material shortages: Fluctuations in API availability due to geopolitical issues, raw material scarcity, or manufacturing disruptions.

  • Regulatory compliance: Ensuring international suppliers meet evolving standards.

  • Supply chain transparency: Traceability of ingredients from origin to finished product to prevent counterfeiting and ensure quality.

  • Cost pressures: Raw material price fluctuations impacting margin and pricing strategies.

Proactively managing these risks involves diversifying the supplier base, conducting rigorous audits, and leveraging strategic partnerships.

Conclusion
The supply of Pediatric Advil hinges on a complex web of API producers, excipient suppliers, packaging providers, contract manufacturers, and logistics partners, each mandated to meet rigorous regulatory standards. Market players must prioritize supply chain resilience, compliance, and quality assurance to ensure an uninterrupted supply of this essential pediatric medication.


Key Takeaways

  • API sourcing is dominated by global leaders like Novartis and Mitsutomo, necessitating vigilant oversight to ensure high-quality ibuprofen supply.
  • Excipients and packaging suppliers ensure Pediatric Advil’s palatability and childproofing, with compliance critical for pediatric safety.
  • Contract manufacturing organizations play a significant role in formulation development and large-scale production, demanding strict quality adherence.
  • Supply chain disruption risks, including raw material shortages and regulatory challenges, require proactive management strategies.
  • Regulatory compliance across borders ensures product safety, reinforcing the importance of transparent supplier relationships and due diligence.

5 FAQs About Pediatric Advil Suppliers

1. Who are the primary API suppliers for Pediatric Advil?
Leading ibuprofen API suppliers include Novartis, Mitsutomo, Ajanta Pharma, and Daiichi Sankyo, all operating under strict GMP standards to ensure product quality.

2. How do excipient suppliers influence Pediatric Advil’s safety?
Excipients from reputable firms like Ingredion and Givaudan are crucial for safety, taste, and stability; their compliance with pharmacopeial standards ensures pediatric safety.

3. What are the risks associated with the supply chain of Pediatric Advil?
Potential risks include raw material shortages, regulatory non-compliance, geopolitical disruptions, and counterfeiting, all impacting supply stability.

4. How do regulatory agencies oversee suppliers involved in Pediatric Advil production?
Agencies like the FDA and EMA enforce GMP standards, conduct audits, and set guidelines to confirm suppliers adhere to quality and safety standards.

5. Why is supply chain diversification important for Pediatric Advil?
Diversification reduces dependency on a single supplier, mitigating risks associated with shortages or disruptions, and ensures consistent product availability.


References

  1. FDA’s Guidance for Industry on Good Manufacturing Practices
  2. European Medicines Agency: Guidelines on Good Manufacturing Practice
  3. Pharmaceutical API Market Reports
  4. WHO Guidelines on Pharmaceutical Quality
  5. Industry reports from Novartis, Ajanta Pharma, Mitsutomo, and other key suppliers

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.